MedTrace Pharma

Minneapolis,  MN 
United States
http://www.medtrace.dk
  • Booth: 4000


Striving to Make O-15 Water Practically Available

MedTrace Pharma is a development stage radiopharmaceutical and device company with headquarters in Minneapolis, MN and Horsholm, Denmark. 
 
We are committed to developing innovative technology to make O-15 water practically available for routine cardiac diagnostic PET imaging. 
 
Our O-15 water and automated manufacturing technology is being investigated under the FDA approved IND #135360 and in the Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered [15-O]-H2O to Identify Coronary Artery Disease During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW) NCT05134012. Researchers interested in this study or other novel applications can contact Emily Vandenbroucke, PhD at emily@medtrace.dk to schedule an appointment or stop by our booth.
 
Please visit MedTrace Pharma Booth #4000 to learn more about our technology and potential collaboration opportunities.

Brands: MedTrace Pharma, [15-O]-H2O injection, O-15 Water, O-15 H2O for diagnostic PET imaging, [O-15]-Water PET Myocardial Perfusion Imaging (MPI), novel PET imaging agent labeled with the radioisotope [15-O], aQuant quantitative imaging software, P3 System (MT-100)

 Videos

Automated O-15 Water Manufacturing Technology

 Products

  • Automated O-15 Water Manufacturing Technology
    For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW)....

    • For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW).
  • O-15 Water Manufacturing Demo at Point of Care
    For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW)....

    • For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW).
  • O-15 Water Manufacturing Demo at Point of Care
    For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW)....

    • For investigational research use only. FDA approved IND #135360 and Phase 3 Study to Confirm Diagnostic Potential of IV Administered [15-O]-H2O to Identify CAD During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW).

Categories

All
  • Automated Synthesis Systems
  • PET
  • PET/CT
  • Radioisotopes
  • Radiopharmaceuticals
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Appointment Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined